Diisopropylethylamine → HCID 58015499, Verbindung
Reaktionsgleichung
[F:1][C:2]1[C:3]([NH:14][NH:15][C:16](=[O:30])[C@H:17]([N:19]2[CH:28]=[CH:27][C:26]3[N:25]=[CH:24][CH:23]=[CH:22][C:21]=3[C:20]2=[O:29])[CH3:18])=[N:4][CH:5]=[C:6]([C:8]2[O:12][N:11]=[C:10]([CH3:13])[CH:9]=2)[CH:7]=1.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.Cl.O=C1N([C@H](C)C(O)=O)C=CC2N=CC=CC1=2.FC1C(NN)=NC=C(C2ON=C(C)C=2)C=1.CCN(C(C)C)C(C)C>C(#N)C.CO>[NH4+:4].[OH-:12].[F:1][C:2]1[C:3]([NH:14][NH:15][C:16](=[O:30])[C@H:17]([N:19]2[CH:28]=[CH:27][C:26]3[N:25]=[CH:24][CH:23]=[CH:22][C:21]=3[C:20]2=[O:29])[CH3:18])=[N:4][CH:5]=[C:6]([C:8]2[O:12][N:11]=[C:10]([CH3:13])[CH:9]=2)[CH:7]=1Komponenten
Edukt 4
Produkt 2
Reagenzien, Katalysatoren, Lösungsmittel 2
Reaktionsbedingungen
- Temperatur
- 0 °C
Versuchsvorschrift
(2R)—N′-(3-fluoro-5-(3-methylisoxazol-5-yl)pyridin-2-yl)-2-(5-oxo-1,6-naphthyridin-6(5H)-yl)propanehydrazide HATU (9.0 g, 24 mmol), (R)-2-(5-oxo-1,6-naphthyridin-6(5H)-yl)propanoic acid hydrochloride and 1-(3-fluoro-5-(3-methylisoxazol-5-yl)pyridin-2-yl)hydrazine (3.6 g, 17 mmol) were taken up in acetonitrile (52 ml, 0.3 M) and cooled to 0° C. DIPEA (8.2 ml, 47 mmol) was added dropwise and the reaction was allowed to stir to room temperature for 30 minutes until complete by LCMS. The crude material was concentrated onto silica gel and then purified via MPLC eluting with 100% DCM to 90% DCM:10% MeOH:1% NH4OH to yield (2R)—N′-(3-fluoro-5-(3-methylisoxazol-5-yl)pyridin-2-yl)-2-(5-oxo-1,6-naphthyridin-6(5H)-yl)propanehydrazide (4.927 g, 77% yield).
Aufarbeitung
- concentrationThe crude material was concentrated onto silica gel
- custompurified via MPLC
- washeluting with 100% DCM to 90% DCM
Quellen und Nachweise
- ORD-Eintrag
- ord-78f6f24d866d479dba320120ada07ff6
- Quelldatensatz
- uspto-grants-2012_06
- Patentnummer
- US08198448B2
Notizen zur Reaktion
Wird geladen…